Revision as of 20:51, 5 May 2010

Bibliography

American Society of Law, Medicine & Ethics, Inc., and Boston University American Journal of Law & Medicine, 2009, 35 Am. J. L. and Med.:
- Highlights
'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at: www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.

@@ Line 2: / Line 2: @@
 =[[Vaccines/Bibliography|Bibliography]]=
 *'''American Society of Law, Medicine & Ethics, Inc., and Boston University American Journal of Law & Medicine, 2009, 35 Am. J. L. and Med.:'''
-** [[Vaccines/Bibliography|Highlights]]
+** [[Vaccines/Bibliography/35 Am. J. L. and Med.|Highlights]]
-*'''Follow-On Biologics: Intellectual Property and Innovation Issues'''
+* 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
-introduces innovation policy issues pertaining to follow-on biologics. @http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
+* Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at:  www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
-*'''Emerging Health Care Issues: Follow-on Biologic Drug Competition'''
+*  Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.
-@www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
 =Navigation=
 Back to [[Main Page]]
 Back to [[Biotechnology_-_Genomic_and_Proteomics]]